IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study.

[1]  G. Prendergast,et al.  Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses , 2020, Frontiers in Immunology.

[2]  M. Suchard,et al.  Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux? , 2019, Front. Cell. Infect. Microbiol..

[3]  L. Cho,et al.  Unique cardiovascular risk factors in women , 2019, Heart.

[4]  S. Luquet,et al.  Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health , 2018, Nature Medicine.

[5]  D. Fuchs,et al.  Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy , 2018, Biological research for nursing.

[6]  E. Lima,et al.  Dysregulation of Tryptophan Catabolism in Metabolic Syndrome. , 2018, Metabolic syndrome and related disorders.

[7]  B. Balkau,et al.  The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation , 2015, Obesity.

[8]  R. Baumgartner,et al.  Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. , 2015, Cardiovascular research.

[9]  T. Lehtimäki,et al.  Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study , 2015, Annals of medicine.

[10]  D. S̆timac,et al.  Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. , 2014, World journal of gastroenterology.

[11]  D. Fuchs,et al.  Obesity‐related dysregulation of the Tryptophan–Kynurenine metabolism: Role of age and parameters of the metabolic syndrome , 2014, Obesity.

[12]  Yong Huang,et al.  A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients. , 2013, Bioanalysis.

[13]  P. Froguel,et al.  CALL FOR PAPERS Integrative and Translational Physiology: Inflammation and Immunity in Organ System Physiology Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone , 2012 .

[14]  Terho Lehtimäki,et al.  Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.

[15]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[16]  L. Jermiin,et al.  Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. , 2007, Gene.

[17]  T. Lehtimäki,et al.  Indoleamine 2,3‐dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study , 2007, Clinical and experimental immunology.

[18]  D. Fuchs,et al.  Chronic immune activation underlies morbid obesity: is IDO a key player? , 2007, Current drug metabolism.

[19]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[20]  Mika Kähönen,et al.  Risk Factors Identified in Childhood and Decreased Carotid Artery Elasticity in Adulthood: The Cardiovascular Risk in Young Finns Study , 2005, Circulation.

[21]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[22]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[23]  T. Laitinen,et al.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.

[24]  D. Munn,et al.  Tryptophan Catabolism and Regulation of Adaptive Immunity , 2003, The Journal of Immunology.

[25]  D. Fuchs,et al.  More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. , 2002, Clinical chemistry.

[26]  T. Lehtimäki,et al.  Trends in serum lipid levels during 1980-1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. , 1997, American journal of epidemiology.

[27]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.